title: Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts.
abstract: BACKGROUND
  Angiotensin II (Ang II) has been implicated in the development of cardiac fibrosis. The aims of the present study were to examine expression and activity of ACE and of angiotensin receptors in human cardiac fibroblasts cultured from dilated cardiomyopathic and ischemic hearts. The effects of Ang II on fibroblasts were also investigated.
  
  
  RESULTS
  Human cardiac fibroblasts were cultured from ventricular and atrial myocardium and characterized immunohistochemically. Expression of ACE and the angiotensin AT1 receptor was demonstrated in cardiac fibroblasts by reverse transcriptase-polymerase chain reaction and radioligand binding. Functional ACE activity, measured by radiolabeled substrate conversion assay, was detected in both ventricular (Vmax. Km-1. mg-1, 0.031+/-0.010; n=13) and atrial (0. 034+/-0.012; n=6) fibroblasts. Fibroblast ACE activity was increased after 48 hours of treatment with basic fibroblast growth factor, dexamethasone, and phorbol ester. Ang II did not affect DNA synthesis but stimulated [3H]proline incorporation in cardiac fibroblasts (20.0+/-4.0% increase above control by 10 micromol/L; P<0.05, n=7), which was abolished by losartan 10 micromol/L but not PD123319 1 micromol/L. Ang II also stimulated a rise in intracellular calcium (basal, 56+/-1 nmol/L; Ang II, 355+/-24 nmol/L) via the AT1 receptor, as shown by complete inhibition with losartan.
  
  
  CONCLUSIONS
  We have demonstrated expression and activity of ACE and AT1 receptor in cultured human cardiac fibroblasts. In addition, cardiac fibroblasts respond to Ang II with AT1 receptor-mediated collagen synthesis. The presence of local ACE and AT1 receptors in human fibroblasts suggests their involvement in the development of cardiac fibrosis.
authors.affiliation: Department of Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College School of Medicine at the Heart Science Centre, Harefield Hospital, Middlesex, UK.
authors.forename: S
authors.initials: S
authors.lastname: Hafizi
authors.forename: J
authors.initials: J
authors.lastname: Wharton
authors.forename: K
authors.initials: K
authors.lastname: Morgan
authors.forename: S P
authors.initials: SP
authors.lastname: Allen
authors.forename: A H
authors.initials: AH
authors.lastname: Chester
authors.forename: J D
authors.initials: JD
authors.lastname: Catravas
authors.forename: J M
authors.initials: JM
authors.lastname: Polak
authors.forename: M H
authors.initials: MH
authors.lastname: Yacoub
mesh_terms: D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism; D005355:Fibrosis; D006801:Humans; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D007703:Peptidyl-Dipeptidase A / Q000096:biosynthesis*; D011945:Receptors, Angiotensin / Q000096:biosynthesis*
chemical_list: D011945:Receptors, Angiotensin; D007703:Peptidyl-Dipeptidase A; D002118:Calcium